J Rello

Summary

Affiliation: Hospital Universitari de Tarragona Joan XXIII
Country: Spain

Publications

  1. doi Ventilator-associated pneumonia: impact of organisms on clinical resolution and medical resources utilization
    Loreto Vidaur
    Critical Care Department, Joan XXIII University Hospital and Pere Virgili Health Institute, Tarragona, Spain
    Chest 133:625-32. 2008
  2. ncbi Etiology of ventilator-associated pneumonia
    Jordi Rello
    Critical Care Department, Joan XXIII University Hospital, University Rovira and Virgili, Carrer Dr Mallafre Guasch 4, Tarragona 43007, Spain
    Clin Chest Med 26:87-95. 2005
  3. ncbi Pharmacokinetics, pharmacodynamics, safety and tolerability of tigecycline
    J Rello
    Critical Care Department, Joan XXIII University Hospital, University Rovira i Virgili, Institut Pere Virgili, Tarragona, Spain
    J Chemother 17:12-22. 2005
  4. ncbi Advances in the management of pneumonia in the intensive care unit: review of current thinking
    J Rello
    Critical Care Department, Joan XXIII University Hospital, University Rovira i Virgili, Tarragona, Spain
    Clin Microbiol Infect 11:30-8. 2005
  5. ncbi Therapy of ventilator-associated pneumonia. A patient-based approach based on the ten rules of "The Tarragona Strategy"
    Alberto Sandiumenge
    Department of Critical Care, Joan XXIII University Hospital, University Rovira and Virgili, C Doctor Mallafré Guasch, 4, 43007, Tarragona, Spain
    Intensive Care Med 29:876-83. 2003
  6. ncbi Incidence, etiology, and outcome of nosocomial pneumonia in ICU patients requiring percutaneous tracheotomy for mechanical ventilation
    Jordi Rello
    Critical Care Department, Joan XXIII University Hospital, University Rovira and Virgili, Carrer Dr Mallafre Guasch 4, 43007 Tarragona, Spain
    Chest 124:2239-43. 2003
  7. ncbi Microbiological testing and outcome of patients with severe community-acquired pneumonia
    Jordi Rello
    Critical Care Department, Joan XXIII University Hospital, Tarragona, Spain
    Chest 123:174-80. 2003
  8. pmc Bench-to-bedside review: Therapeutic options and issues in the management of ventilator-associated bacterial pneumonia
    Jordi Rello
    Critical Care Department, Joan XXIII University Hospital, University Rovira i Virgili, Institut Pere Virgili, Tarragona, Spain
    Crit Care 9:259-65. 2005
  9. ncbi [Nosocomial pneumonia: local response to a global problem]
    Jordi Rello
    Servicio de Medicina Intensiva, Hospital Universitario Joan XXIII, Tarragona, Espana
    Enferm Infecc Microbiol Clin 23:1. 2005
  10. ncbi Why do physicians not follow evidence-based guidelines for preventing ventilator-associated pneumonia?: a survey based on the opinions of an international panel of intensivists
    Jordi Rello
    Critical Care Department, University Hospital Joan XXIII, University Rovira and Virgili, Tarragona, Spain
    Chest 122:656-61. 2002

Detail Information

Publications104 found, 100 shown here

  1. doi Ventilator-associated pneumonia: impact of organisms on clinical resolution and medical resources utilization
    Loreto Vidaur
    Critical Care Department, Joan XXIII University Hospital and Pere Virgili Health Institute, Tarragona, Spain
    Chest 133:625-32. 2008
    ..The aim of this study was to evaluate the influence of organisms and their susceptibility to treatment on outcomes...
  2. ncbi Etiology of ventilator-associated pneumonia
    Jordi Rello
    Critical Care Department, Joan XXIII University Hospital, University Rovira and Virgili, Carrer Dr Mallafre Guasch 4, Tarragona 43007, Spain
    Clin Chest Med 26:87-95. 2005
    ..The discussion herein analyzes these aspects, placing particular emphasis on risk factors, attributable mortality, resistance, and the implications for management...
  3. ncbi Pharmacokinetics, pharmacodynamics, safety and tolerability of tigecycline
    J Rello
    Critical Care Department, Joan XXIII University Hospital, University Rovira i Virgili, Institut Pere Virgili, Tarragona, Spain
    J Chemother 17:12-22. 2005
    ..C. difficile-related complications with tigecycline are uncommon. In the majority of patients, tigecycline has minimal adverse effects on blood chemistry or haematology...
  4. ncbi Advances in the management of pneumonia in the intensive care unit: review of current thinking
    J Rello
    Critical Care Department, Joan XXIII University Hospital, University Rovira i Virgili, Tarragona, Spain
    Clin Microbiol Infect 11:30-8. 2005
    ..Therefore, antibiotic choice should be institution-specific and patient-oriented...
  5. ncbi Therapy of ventilator-associated pneumonia. A patient-based approach based on the ten rules of "The Tarragona Strategy"
    Alberto Sandiumenge
    Department of Critical Care, Joan XXIII University Hospital, University Rovira and Virgili, C Doctor Mallafré Guasch, 4, 43007, Tarragona, Spain
    Intensive Care Med 29:876-83. 2003
    ..The choice of initial antibiotic should be based on the patient's previous antibiotic exposure and comorbidities, and local antibiotic susceptibility patterns, which should be updated regularly...
  6. ncbi Incidence, etiology, and outcome of nosocomial pneumonia in ICU patients requiring percutaneous tracheotomy for mechanical ventilation
    Jordi Rello
    Critical Care Department, Joan XXIII University Hospital, University Rovira and Virgili, Carrer Dr Mallafre Guasch 4, 43007 Tarragona, Spain
    Chest 124:2239-43. 2003
    ..To determine the epidemiology of pneumonia in patients with tracheotomy receiving short-term mechanical ventilation...
  7. ncbi Microbiological testing and outcome of patients with severe community-acquired pneumonia
    Jordi Rello
    Critical Care Department, Joan XXIII University Hospital, Tarragona, Spain
    Chest 123:174-80. 2003
    ..The study documents the impact of microbiological investigations on therapeutic decisions and outcome in patients with severe community-acquired pneumonia (SCAP)...
  8. pmc Bench-to-bedside review: Therapeutic options and issues in the management of ventilator-associated bacterial pneumonia
    Jordi Rello
    Critical Care Department, Joan XXIII University Hospital, University Rovira i Virgili, Institut Pere Virgili, Tarragona, Spain
    Crit Care 9:259-65. 2005
    ..More active, less toxic antibacterial agents are still needed, in particular to combat problematic pathogens such as multiresistant Gram-negative bacilli and resistant Gram-positive organisms (e.g. methicillin-resistant S aureus)...
  9. ncbi [Nosocomial pneumonia: local response to a global problem]
    Jordi Rello
    Servicio de Medicina Intensiva, Hospital Universitario Joan XXIII, Tarragona, Espana
    Enferm Infecc Microbiol Clin 23:1. 2005
  10. ncbi Why do physicians not follow evidence-based guidelines for preventing ventilator-associated pneumonia?: a survey based on the opinions of an international panel of intensivists
    Jordi Rello
    Critical Care Department, University Hospital Joan XXIII, University Rovira and Virgili, Tarragona, Spain
    Chest 122:656-61. 2002
    ..Adherence to clinical practice guidelines is highly variable. Our objective was to review barriers to physicians' adherence to evidence-based guidelines (EBGs) for preventing ventilator-associated pneumonia (VAP)...
  11. ncbi Implications of COPD in patients admitted to the intensive care unit by community-acquired pneumonia
    J Rello
    Critical Care Dept, Joan XXIII University Hospital, Carrer Mallafre Guasch 4, E43007 Tarragona, Spain
    Eur Respir J 27:1210-6. 2006
    ....
  12. ncbi De-escalation therapy in ventilator-associated pneumonia
    Jordi Rello
    Critical Care Department, Joan XXIII University Hospital, University Rovira i Virgili, Tarragona, Spain
    Crit Care Med 32:2183-90. 2004
    ..To evaluate de-escalation of antibiotic therapy in patients with ventilator-associated pneumonia...
  13. doi First influenza season after the 2009 pandemic influenza: report of the first 300 ICU admissions in Spain
    A Rodriguez
    Hospital Joan XXIII, Critical Care Department, IISPV, URV, CIBER Enfermedades Respiratorias, Tarragona, Spain
    Med Intensiva 35:208-16. 2011
    ..During the 2009 influenza pandemic, several reports were published, nevertheless, data on the clinical profiles of critically ill patients with the new virus infection during this second outbreak are still lacking...
  14. ncbi Antibacterial treatment of invasive mechanical ventilation-associated pneumonia
    F Barcenilla
    Servicio de Medicina Intensiva, Hospital Universitario Arnau de Vilanova, Lleida, Spain
    Drugs Aging 18:189-200. 2001
    ..However, the choice of the antibacterial regimen should follow local guidelines of treatment based upon the knowledge of the most frequently isolated bacterial flora and their susceptibilities in different clinical settings...
  15. doi A randomized trial of dental brushing for preventing ventilator-associated pneumonia
    Angel Pobo
    Critical Care Department, Joan XXIII University Hospital, 43007 Tarragona, Spain
    Chest 136:433-9. 2009
    ..Poor oral hygiene is associated with respiratory pathogen colonization and secondary lung infection. The impact of adding electric toothbrushing to oral care in order to reduce ventilator-associated pneumonia (VAP) incidence is unknown...
  16. doi [Pandemic influenza A in the ICU: experience in Spain and Latin America. GETGAG/SEMICYUC/(Spanish Working Group on Severe Pandemic Influenza A/SEMICYUC)]
    A Rodriguez
    Unidad de Cuidados Intensivos, Hospital Joan XXIII, CIBER Enfermedades Respiratorias, IISPV, Tarragona, Espana
    Med Intensiva 34:87-94. 2010
    ..It has spread very rapidly since the first cases were diagnosed in Mexico with the subsequent spread of the virus throughout the Southern Cone and Europe during the summer season...
  17. ncbi Antibiotic prescription for community-acquired pneumonia in the intensive care unit: impact of adherence to Infectious Diseases Society of America guidelines on survival
    M Bodi
    Intensive Care Dept, Joan XXIII University Hospital, Tarragona, Spain
    Clin Infect Dis 41:1709-16. 2005
    ..The purpose of our study was to analyze prognostic factors associated with mortality for patients with severe community-acquired pneumonia (CAP)...
  18. ncbi International Conference for the Development of Consensus on the Diagnosis and Treatment of Ventilator-associated Pneumonia
    J Rello
    Hospital Universitari Joan XXIII, Tarragona, Spain
    Chest 120:955-70. 2001
    ..Consensus was reached on the importance of local epidemiology surveillance programs and on the need for customized empiric antimicrobial choices to respond to local patterns of pathogens and susceptibilities...
  19. doi Determinants of prescription and choice of empirical therapy for hospital-acquired and ventilator-associated pneumonia
    J Rello
    Critical Care Department, Vall d Hebron University Hospital, Vall d Hebron Institut de Recerca, Universitat Autonoma de Barcelona, Passeig de la Vall d Hebron, 119 129, 08035, Barcelona, Spain
    Eur Respir J 37:1332-9. 2011
    ..Across Europe, carbapenems were the antibiotic most prescribed for HAP/VAP...
  20. ncbi Associations between empirical antimicrobial therapy at the hospital and mortality in patients with severe community-acquired pneumonia
    J Rello
    Critical Care Department, University Hospital Joan XXIII, Mallafre Guasch 4, 43007 Tarragona
    Intensive Care Med 28:1030-5. 2002
    ..The aim of the study was to examine different antibiotic choices and their relation to outcomes...
  21. ncbi [Infection associated with the use of assisted-ventilation devices]
    Emili Diaz
    Servicio Medicina Intensiva, Hospital Universitari Joan XXIII, Tarragona, Spain
    Enferm Infecc Microbiol Clin 26:465-70. 2008
    ....
  22. doi Why mortality is increased in health-care-associated pneumonia: lessons from pneumococcal bacteremic pneumonia
    Jordi Rello
    Critical Care Department, Joan XXIII University Hospital, Carrer Mallafre Guasch, 4, Tarragona 43007, Spain
    Chest 137:1138-44. 2010
    ..A cohort of patients with bacteremic Streptococcus pneumoniae pneumonia was reviewed to assess why mortality is higher in health-care-associated pneumonia (HCAP) than in community-acquired pneumonia (CAP)...
  23. doi Use of early corticosteroid therapy on ICU admission in patients affected by severe pandemic (H1N1)v influenza A infection
    I Martin-Loeches
    Critical Care Department, Joan XXIII University Hospital, University Rovira i Virgili, IISPV, CIBER Enfermedades Respiratorias CIBERES, Tarragona, Spain
    Intensive Care Med 37:272-83. 2011
    ..Early use of corticosteroids in patients affected by pandemic (H1N1)v influenza A infection, although relatively common, remains controversial...
  24. doi Early non-invasive ventilation treatment for severe influenza pneumonia
    J R Masclans
    Critical Care Department, Vall d Hebron University Hospital, Vall d Hebron Research Institute VHIR, Universitat Autonoma de Barcelona, Barcelona, Spain
    Clin Microbiol Infect 19:249-56. 2013
    ..6% of them. NIV success was associated with shorter hospital stay and mortality similar to non-ventilated patients. NIV failure was associated with a mortality similar to those who were intubated from the start...
  25. ncbi Impact of Gram-positive resistance on outcome of nosocomial pneumonia
    M Bodi
    Department of Critical Care, Hospital Universitari Joan XXIII, University Rovira i Virgili, Tarragona, Spain
    Crit Care Med 29:N82-6. 2001
    ..Optimizing treatment focusing on this goal and new antimicrobials provide new opportunities to improve survival. (Crit Care Med 2001; 29[Suppl.]:N82-N86)..
  26. ncbi [Clinical approach to the patient with ventilator-associated pneumonia]
    Loreto Vidaur
    Servicio de Medicina Intensiva, Hospital Universitario Joan XXIII, Tarragona, Espana
    Enferm Infecc Microbiol Clin 23:18-23. 2005
    ..Recent studies suggest that shorter antibiotic regimens reduce the emergence of antibiotic-resistant pathogens, cost and adverse events...
  27. doi Elevation of creatine kinase is associated with worse outcomes in 2009 pH1N1 influenza A infection
    Bárbara Borgatta
    Critical Care Department, Vall d Hebron University Hospital, Universitat Autonoma de Barcelona UAB, 08035, Barcelona, Spain
    Intensive Care Med 38:1152-61. 2012
    ..Current medical knowledge lacks specific information regarding creatine kinase (CK) elevation in influenza A pH1N1 (2009) infection...
  28. doi PIRO score for community-acquired pneumonia: a new prediction rule for assessment of severity in intensive care unit patients with community-acquired pneumonia
    Jordi Rello
    Critical Care Department, Joan XXIII University Hospital, University Rovira and Virgili, Institut Pere Virgili, CIBER Enfermedades Respiratorias, Tarragona, Spain
    Crit Care Med 37:456-62. 2009
    ....
  29. ncbi Pneumonia in the intensive care unit
    Jordi Rello
    Critical Care Department, Joan XXII University Hospital, University Rovira i Virgili, Taragona, Spain
    Crit Care Med 31:2544-51. 2003
    ..To update the state-of-the-art on pneumonia in adult patients in the intensive care unit (ICU), with special emphasis on new developments in management...
  30. doi [Mechanical ventilation associated pneumonia]
    E Diaz
    Servicio de Medicina Intensiva, Hospital Universitari Joan XXIII Tarragona, Universitat Rovira i Virgili, IISPV, CIBER Enfermedades Respiratorias, CibeRes, Tarragona, Spain
    Med Intensiva 34:318-24. 2010
    ....
  31. ncbi Hospital-acquired pneumonia in the 21st century: a review of existing treatment options and their impact on patient care
    Despoina Koulenti
    Critical Care Department, Joan XXIII University Hospital Institut Pere Virgili, Mallafre Guasch, 4, 43007 Tarragona, Spain
    Expert Opin Pharmacother 7:1555-69. 2006
    ..The optimal duration of treatment is a matter of debate, but courses longer than 1 week are rarely justified...
  32. ncbi Impact of diversity of antibiotic use on the development of antimicrobial resistance
    Alberto Sandiumenge
    Critical Care Department, Joan XXIII University Hospital, University Rovira i Virgili Institut Pere Virgili, Tarragona 43007, Spain
    J Antimicrob Chemother 57:1197-204. 2006
    ..To evaluate the impact of different antibiotic strategies on acquisition of resistant microorganisms...
  33. doi Mortality in ICU patients with bacterial community-acquired pneumonia: when antibiotics are not enough
    Alejandro Rodriguez
    Critical Care Department, Pere Virgili Health Institut and CIBER Enfermedades Respiratorias, Joan XXIII University Hospital, Tarragona, Spain
    Intensive Care Med 35:430-8. 2009
    ..It remains uncertain why immunocompetent patients with bacterial community-acquired pneumonia (CAP) die, in spite of adequate antibiotics...
  34. ncbi Pneumonia caused by oxacillin-resistant Staphylococcus aureus treated with glycopeptides
    Jordi Rello
    Joan XXIII University Hospital, University Rovira and Virgili, Institut Pere Virgili, Tarragona, Spain
    Crit Care Med 33:1983-7. 2005
    ..To determine whether ventilator-associated pneumonia caused by oxacillin-resistant Staphylococcus aureus (VAP-ORSA) treated with glycopeptides is associated with an increased mortality rate...
  35. ncbi Nosocomial lung infections in adult intensive care units
    Gonzalo Hernandez
    Critical Care Department, 12, de Octubre University Hospital, University Complutense, Madrid, Spain
    Microbes Infect 6:1004-14. 2004
    ..Nosocomial pneumonias are often difficult to treat due to antibiotic-resistant bacteria. Antibiotic policies are crucial in avoiding a progression in antibiotic resistance...
  36. ncbi Nursing adherence with evidence-based guidelines for preventing ventilator-associated pneumonia
    Maite Ricart
    Critical Care Department, Joan XXIII University Hospital, Universitat Rovira i Virgili, Tarragona, Spain
    Crit Care Med 31:2693-6. 2003
    ..To review barriers to nursing adherence to nonpharmacologic evidence-based guidelines for preventing ventilator-associated pneumonia...
  37. ncbi Risk factors for ventilator-associated pneumonia by Pseudomonas aeruginosa in presence of recent antibiotic exposure
    Jordi Rello
    Critical Care Department, Joan XXIII University Hospital, University Rovira and Virgili, Institut Pere Virgili, Carrer Dr Mallafre Guasch 4, 43007 Tarragona, Spain
    Anesthesiology 105:709-14. 2006
    ....
  38. ncbi Risk factors for pneumonia in the intubated patient
    Olga Diaz
    Critical Care Department, Hospital Doce de Octubre, Madrid, Spain
    Infect Dis Clin North Am 17:697-705. 2003
    ..This variable should be considered when stratifying patients for risk factor analysis and also in the design of clinical trials for VAP prophylaxis...
  39. ncbi Combination antibiotic therapy improves survival in patients with community-acquired pneumonia and shock
    Alejandro Rodriguez
    Intensive Care Unit, Joan XXIII University Hospital, Tarragona, Spain
    Crit Care Med 35:1493-8. 2007
    ..To assess whether combination antibiotic therapy improves outcome of severe community-acquired pneumonia in the subset of patients with shock...
  40. doi [Antifungal prophylaxis in the postoperative period of lung transplant surgery in Spain]
    J Sacanell
    Servicio de Medicina Intensiva, Hospital Universitario Vall d Hebron, Barcelona, Espana
    Med Intensiva 37:201-5. 2013
    ..To examine the type and duration of antifungal prophylaxis provided during the postoperative period of lung transplant recipients, together with the most frequent complications during admission to Intensive Care Units in Spain...
  41. doi First influenza season after the 2009 pandemic influenza: characteristics of intensive care unit admissions in adults and children in Vall d'Hebron Hospital
    G Poulakou
    Department of Critical Care, Vall d Hebron University Hospital, Barcelona, Spain
    Clin Microbiol Infect 18:374-80. 2012
    ..Increasing vaccination rates among risk-group individuals is warranted to prevent ICU admission and death...
  42. ncbi [Prevention of nosocomial infections: strategies to improve the safety of the patients in the Intensive Care Unit]
    T Lisboa
    Servicio de Cuidados Intensivos, Hospital Universitario Joan XXIII, Universidad Rovira y Virgili, Instituto Pere Virgili, Tarragona, Espana
    Med Intensiva 32:248-52. 2008
    ..Using care bundles, continuing education and feedback on adherence to the measures proposed are key points to improve the safety of patients in the Intensive Care Unit...
  43. ncbi Clinical approach to the patient with suspected ventilator-associated pneumonia
    Loreto Vidaur
    Critical Care Department, University Rovira and Virgili Institut Pere Virgili, Joan XXIII University Hospital, Carrer Dr Mallafre Guasch 4, 43007 Tarragona, Spain
    Respir Care 50:965-74; discussion 974. 2005
    ..Optimal management should be based on a strategy combining early high doses of an effective agent for a short period of time, which is then simplified in the light of microbiologic information...
  44. pmc Demographics, guidelines, and clinical experience in severe community-acquired pneumonia
    Jordi Rello
    Critical Care Department, Joan XXIII University Hospital University Rovira i Virgili, Pere Virgili Health Institut, CIBER Enfermedades Respiratorias CIBERES, Tarragona 43007, Spain
    Crit Care 12:S2. 2008
    ....
  45. ncbi Epidemiology and outcomes of ventilator-associated pneumonia in a large US database
    Jordi Rello
    University Hospital Joan XXIII, University Rovira and Virgili, Tarragona, Spain
    Chest 122:2115-21. 2002
    ..To evaluate risk factors for ventilator-associated pneumonia (VAP), as well as its influence on in-hospital mortality, resource utilization, and hospital charges...
  46. pmc Intensive care adult patients with severe respiratory failure caused by Influenza A (H1N1)v in Spain
    Jordi Rello
    Critical Care Department, Joan XXIII University Hospital, CIBERes Enfermedades Respiratorias, IISPV, Mallafre Guasch 4, 43007 Tarragona, Spain
    Crit Care 13:R148. 2009
    ..We describe the clinical and epidemiologic characteristics of the first 32 persons reported to be admitted to the intensive care unit (ICU) due to influenza A (H1N1)v infection in Spain...
  47. ncbi Reduced burden of bacterial airway colonization with a novel silver-coated endotracheal tube in a randomized multiple-center feasibility study
    Jordi Rello
    Critical Care Department, Joan XXIII University Hospital, Tarragona, Spain
    Crit Care Med 34:2766-72. 2006
    ..To assess the feasibility and safety of the respiratory infection control (RIC) device, a silver-coated endotracheal tube, and its effect on bacterial burden in the airways...
  48. doi Radiologic progression of pulmonary infiltrates predicts a worse prognosis in severe community-acquired pneumonia than bacteremia
    Thiago Lisboa
    Critical Care Department, Joan XXIII University Hospital, CIBER Enfermedades Respiratorias, Carrer Mallafre Guasch, Tarragona, Spain
    Chest 135:165-72. 2009
    ..The objective of this study was to investigate the relative importance of these two factors in the outcome of patients with severe CAP (sCAP)...
  49. ncbi Management of ventilator-associated pneumonia caused by multiresistant bacteria
    Emili Diaz
    Critical Care Department, Joan XXIII University Hospital, University Rovira and Virgili Institut Pere Virgili, Tarragona Spain
    Curr Opin Crit Care 13:45-50. 2007
    ..The inappropriate choice of antibiotics (in nearly one third of episodes) is the most important risk factor for death. Traditionally, a narrow-spectrum drug was used first, and the most potent drugs were reserved for subsequent use...
  50. doi The ventilator-associated pneumonia PIRO score: a tool for predicting ICU mortality and health-care resources use in ventilator-associated pneumonia
    Thiago Lisboa
    Critical Care Department, Joan XXIII University Hospital, Tarragona, Spain
    Chest 134:1208-16. 2008
    ..No score is available to assess severity and stratify mortality risk in ventilator-associated pneumonia (VAP). Our objective was to develop a severity assessment tool for VAP patients...
  51. ncbi Effects of high-dose of intravenous immunoglobulin and antibiotics on survival for severe sepsis undergoing surgery
    Alejandro Rodriguez
    Intensive Care Department of Joan XXIII University Hospital University Rovira and Virgili and Institut Pere Virgili, Tarragona, Spain
    Shock 23:298-304. 2005
    ..We conclude that IVIG administration, when used in combination with adequate antibiotics, improved the survival of surgical ICU patients with intra-abdominal sepsis. The initial choice of antibiotic has a dramatic impact on outcome...
  52. ncbi Ventilator-associated pneumonia: issues related to the artificial airway
    Emili Diaz
    Critical Care Department, University Rovira and Virgili Institut Pere Virgili, Joan XXIII University Hospital, Carrer Dr Mallafre Guasch 4, 43007 Tarragona, Spain
    Respir Care 50:900-6; discussion 906-9. 2005
    ..As many studies suggest that incidence of VAP is highly dependent on the strategies of airway management, health care workers should be alerted to issues related to the artificial airway...
  53. ncbi Clinical resolution in patients with suspicion of ventilator-associated pneumonia: a cohort study comparing patients with and without acute respiratory distress syndrome
    Loreto Vidaur
    Critical Care Department, Joan XXIII University Hospital, University Rovira and Virgili, Tarragona, Spain
    Crit Care Med 33:1248-53. 2005
    ..A secondary objective was to identify clinical variables that might be useful for monitoring response to therapy...
  54. doi Differences in hospital- and ventilator-associated pneumonia due to Staphylococcus aureus (methicillin-susceptible and methicillin-resistant) between Europe and Latin America: a comparison of the EUVAP and LATINVAP study cohorts
    J Rello
    Critical Care Department, Vall d Hebron University Hospital, IRVH, CibeRes, Barcelona, Spain
    Med Intensiva 37:241-7. 2013
    ..the European Union VAP (EUVAP) cohorts of patients admitted to intensive care units (ICUs)...
  55. doi The sounds of cardiac arrest: innovating to obtain an accurate record during in-hospital cardiac arrest
    N Duran
    Critical Care Department, Vall d Hebron University Hospital, Research Group in Shock, Multiorgan Dysfunction and Resuscitation, Vall d Hebron Institute of Research, Universitat Autonoma de Barcelona, Spain
    Resuscitation 83:1219-22. 2012
    ..To obtain an accurate audit during in-hospital cardiac arrest, following recommendations of the Utstein style and measuring time intervals between the different interventions, is difficult...
  56. doi Solid organ transplant training objectives for residents
    J R Masclans
    Servicio de Medicina Intensiva, Hospital Vall d Hebron de Barcelona, Instituto de Investigación Vall d Hebron, Universitat Autonoma de Barcelona, CibeRes, Spain
    Med Intensiva 36:584-8. 2012
    ..We conclude that we need a specific training program in complications of SOT, as well as fundamental principles in immunology and immunosuppressor pharmacology...
  57. ncbi Endotracheal tube intraluminal diameter narrowing after mechanical ventilation: use of acoustic reflectometry
    M C Boque
    University Hospital Joan XXIII, University Rovira i Virgili, Mallafre Guasch 4, 43007 Tarragona, Spain
    Intensive Care Med 30:2204-9. 2004
    ..To quantify the incidence and degree of endotracheal tube intraluminal obstruction after mechanical ventilation and its relation to time of intubation...
  58. ncbi Prevention of infection in the intensive care unit: current advances and opportunities for the future
    Carmen Lorente
    Critical Care Department, University Hospital Joan XXIII, University Rovira and Virgili, Tarragona, Spain
    Curr Opin Crit Care 8:461-4. 2002
    ..Potential measures of control should focus on the patient, the microorganisms, and the device. A number of recent studies addressing these issues have been published and will be reviewed in this article...
  59. ncbi Management of ventilator-associated pneumonia in a multidisciplinary intensive care unit: does trauma make a difference?
    Kemal Agbaht
    CIBER Enfermedades Respiratorias, University of Rovira and Virgili, Critical Care Department, Joan XXIII University Hospital, Institut Pere Virgili, Carrer Dr Mallafre Guasch 4, 43007 Tarragona, Spain
    Intensive Care Med 33:1387-95. 2007
    ..Antibiotic exposure and timing of pneumonia onset influence ventilator-associated pneumonia (VAP) isolates. The first goal of this investigation was to evaluate whether trauma also influences prevalence of microorganisms...
  60. doi Ventilator-associated pneumonia in trauma patients is associated with lower mortality: results from EU-VAP study
    M Magret
    Critical Care Department, Sant Joan University Hospital, Reus, Spain
    J Trauma 69:849-54. 2010
    ..Differences in trauma patients developing ventilator-associated pneumonia (VAP) are described regarding etiology and risk factors associated. We aim to describe the differences in outcomes in trauma and nontrauma patients with VAP...
  61. ncbi Top ten list in antibiotic policy in the ICU
    Emili Diaz
    Critical Care Department, Joan XXIII University Hospital, Tarragona, Spain
    Chest 122:712-4. 2002
  62. doi Management of ventilator-associated pneumonia
    Emili Diaz
    Critical Care Department, Joan XXIII University Hospital, University Rovira i Virgili, IISPV, CIBER Enfermedades Respiratorias, Carrer Mallafre Guasch 4, Tarragona 43007, Spain
    Infect Dis Clin North Am 23:521-33. 2009
    ..In recent years, a more dynamic approach has evolved, updating local epidemiology, evaluating VAP and diagnostic tools every day, and assessing host response using clinical and biochemical parameters...
  63. ncbi Bacteremia in patients with ventilator-associated pneumonia is associated with increased mortality: A study comparing bacteremic vs. nonbacteremic ventilator-associated pneumonia
    Kemal Agbaht
    Critical Care Department, Joan XXIII University Hospital, University Rovira i Virgili, Institut Pere Virgili, Tarragona, Spain
    Crit Care Med 35:2064-70. 2007
    ..To assess whether bacteremic ventilator-associated pneumonia (B-VAP) differs in terms of risk factors, organisms, and outcomes from nonbacteremic VAP (NB-VAP)...
  64. ncbi Oral care practices in intensive care units: a survey of 59 European ICUs
    Jordi Rello
    Joan XXIII University Hospital, Critical Care Department, Mallafre Guasch 4, 43007 Tarragona, Spain
    Intensive Care Med 33:1066-70. 2007
    ..To explore the type and frequency of oral care practices in European ICUs and the attitudes, beliefs, and knowledge of health care workers...
  65. ncbi C-reactive protein correlates with bacterial load and appropriate antibiotic therapy in suspected ventilator-associated pneumonia
    Thiago Lisboa
    Critical Care Department, Joan XXIII University Hospital, University Rovira and Virgili, Institut Pere Virgili, CIBER Enfermedades Respiratorias, Tarragona, Spain
    Crit Care Med 36:166-71. 2008
    ....
  66. doi Severity of pneumococcal pneumonia associated with genomic bacterial load
    Jordi Rello
    Critical Care Department, Hospital Universitari Joan XXIII, 43007 Tarragona, Spain
    Chest 136:832-40. 2009
    ..As viral load is useful in viral infections, we hypothesized that bacterial load may be associated with outcomes in patients with pneumococcal pneumonia...
  67. doi Diagnosis of ventilator-associated pneumonia: is there a gold standard and a simple approach?
    Thiago Lisboa
    Critical Care Department, Joan XXIII University Hospital, University Rovira and Virgili, Institut Pere Virgili, CIBER Enfermedades Respiratorias, Tarragona, Spain
    Curr Opin Infect Dis 21:174-8. 2008
    ..Recent findings in diagnosis are reviewed here...
  68. doi A European care bundle for prevention of ventilator-associated pneumonia
    Jordi Rello
    Critical Care Department, Vall d Hebron University Hospital, Institut de Recerca Vall d Hebron UAB, CibeRes, Barcelona, Spain
    Intensive Care Med 36:773-80. 2010
    ..One recent approach to facilitating guideline implementation involves the use of care bundles...
  69. pmc The simple and the simpler in pneumonia diagnosis
    Thiago Lisboa
    Critical Care Department, Joan XXIII University Hospital, University Rovira and Virgili, Institut Pere Virgili, CIBERes Enfermedades Respiratorias, Carrer Mallafre Guasch, 4 43007, Tarragona, Spain
    Crit Care 11:140. 2007
    ....
  70. ncbi Association between 4G/5G polymorphism of the plasminogen activator inhibitor 1 gene with stroke or encephalopathy after cardiac surgery
    Gonzalo Sirgo
    Intensive Care Department, Joan XXIII University Hospital, University Rovira i Virgili, Institut Pere Virgili, Mallafre Guasch N 4, 43007, Tarragona, Spain
    Intensive Care Med 32:668-75. 2006
    ....
  71. ncbi Gram-negative bacterial pneumonia: aetiology and management
    Despoina Koulenti
    Critical Care Department, Joan XXIII University Hospital, University Rovira y Virgili Institut PereVirgili, Tarragona, Spain
    Curr Opin Pulm Med 12:198-204. 2006
    ..Recent articles of clinical and investigational interest on Gram-negative pneumonia, particularly hospital-acquired and ventilator-associated pneumonia, are reviewed...
  72. ncbi Influence of renal function on the pharmacokinetics of piperacillin/tazobactam in intensive care unit patients during continuous venovenous hemofiltration
    Alazne Arzuaga
    Laboratorio de Farmacia y Tecnología Farmacéutica, Facultad de Farmacia, Paseo de la Universidad no 7, 01006 Vitoria Gasteiz, Spain
    J Clin Pharmacol 45:168-76. 2005
    ..The extracorporeal clearance of piperacillin/tazobactam is clinically significant in patients with CL(CR) > 50 mL/min, in which the risk of underdosing and clinical failure is important and extra doses are required...
  73. ncbi Acinetobacter baumannii: a threat for the ICU?
    Jordi Rello
    Intensive Care Med 29:350-1. 2003
  74. ncbi Prospective observational study of bacteremic pneumococcal pneumonia: Effect of discordant therapy on mortality
    Manel Lujan
    Pulmonary Department, Corporacio Parc Tauli, Sabadell, Barcelona, Spain
    Crit Care Med 32:625-31. 2004
    ..To evaluate the effect of discordant empirical therapy on outcome in bacteremic pneumococcal community-acquired pneumonia...
  75. ncbi Impact of antibiotic guideline compliance on duration of mechanical ventilation in critically ill patients with community-acquired pneumonia
    Andrew F Shorr
    Pulmonary and Critical Care Section, Department of Medicine, Room 2A 38D, Washington Hospital Center, Washington, DC 20010, USA
    Chest 130:93-100. 2006
    ..Our goal was to assess the impact of following these guidelines, such as those from the Infectious Disease Society of America (IDSA), on the duration of mechanical ventilation (MV)...
  76. ncbi [Cyclic rotation of antibiotics. Is all that glitters gold?]
    Alberto Sandiumenge
    Servicio de Cuidados Intensivos Hospital Universitario Joan XXIII Universitat Rovira i Virgili Tarragona España
    Enferm Infecc Microbiol Clin 21:93-100. 2003
    ..In this article several methodological considerations are suggested for future studies testing this new antibiotic strategy...
  77. ncbi Optimal therapy for severe pneumococcal community-acquired pneumonia
    Manel Lujan
    Pulmonary Service, Corporació Parc Taulí Institut Universitari Parc Taulí, Sabadell, Spain
    Intensive Care Med 32:971-80. 2006
    ..Prospective, randomized clinical trials of pneumonia patients with a pneumonia severity index score above 90 are warranted to define optimal antibiotic regimens...
  78. ncbi Changing physicians' behavior in the intensive care unit
    Jordi Rello
    Crit Care Med 30:2593-4. 2002
  79. ncbi Antibiotic use and the risk of pneumonia: 20 years of studies, but where are we now?
    Emili Diaz
    Clin Infect Dis 38:1409-11. 2004
  80. ncbi Patterns of colonization by Pseudomonas aeruginosa in intubated patients: a 3-year prospective study of 1,607 isolates using pulsed-field gel electrophoresis with implications for prevention of ventilator-associated pneumonia
    Jordi Valles
    Critical Care Center, Hospital Sabadell and UDIAT Diagnostic Center, Institut Universitari, Universitat Autonoma Barcelona, Parc Tauli s n, 08208 Sabadell, Spain
    Intensive Care Med 30:1768-75. 2004
    ..To identify routes and patterns of colonization with Pseudomonas aeruginosa in intubated patients to design strategies of prevention for respiratory infection...
  81. ncbi Type III protein secretion is associated with poor clinical outcomes in patients with ventilator-associated pneumonia caused by Pseudomonas aeruginosa
    Alan R Hauser
    Department of Microbiology Immunology, Northwestern University, Chicago, IL, USA
    Crit Care Med 30:521-8. 2002
    ..The objective of this study was to determine whether this system contributes to disease severity in humans with ventilator-associated pneumonia...
  82. pmc Choosing the right combination therapy in severe community-acquired pneumonia
    Grant W Waterer
    School of Medicine and Pharmacology, University of Western Australia, MRF Building, Royal Perth Hospital, GPO Box X2213, Perth 6847, Australia
    Crit Care 10:115. 2006
    ..Several mechanisms exist by which quinolones could be inferior to macrolides in combination therapy, so if these findings are confirmed by other groups they have significant implications for physicians treating patients with severe CAP...
  83. ncbi Benefits of minocycline and rifampin-impregnated central venous catheters. A prospective, randomized, double-blind, controlled, multicenter trial
    Cristóbal León
    Intensive Care Unit, Hospital Universitario de Valme, Universidad de Sevilla, Carretera de Cádiz s n, 41014 Sevilla, Spain
    Intensive Care Med 30:1891-9. 2004
    ..To determine the efficacy of minocycline and rifampin-impregnated catheters compared to non-impregnated catheters in critically ill patients...
  84. ncbi Prevention and diagnosis of ventilator-associated pneumonia: a survey on current practices in Southern Spanish ICUs
    Rafael Sierra
    Intensive Care Unit, Puerta del Mar University Hospital, University of Cadiz, Spain
    Chest 128:1667-73. 2005
    ..To assess the implementation of selected ventilator-associated pneumonia (VAP) prevention strategies, and to learn how VAP is diagnosed in the ICUs of Southern Spain...
  85. ncbi Drug-resistant pneumococcal pneumonia: clinical relevance and related factors
    Javier Aspa
    Servicio de Neumologia, Hospital de la Princesa, Madrid, Spain
    Clin Infect Dis 38:787-98. 2004
    ..In summary, the rate of resistance to beta -lactams and macrolides among S. pneumoniae that cause CAP remains high, but such resistance does not result in increased morbidity...
  86. ncbi Community-acquired bloodstream infection in critically ill adult patients: impact of shock and inappropriate antibiotic therapy on survival
    Jordi Valles
    Intensive Care Department, Hospital de Sabadell, Spain
    Chest 123:1615-24. 2003
    ....
  87. ncbi Optimal management therapy for Pseudomonas aeruginosa ventilator-associated pneumonia: an observational, multicenter study comparing monotherapy with combination antibiotic therapy
    Jose Garnacho-Montero
    Critical Care and Emergency Department, Hospital Universitario Virgen del Rocio, Sevilla, Spain
    Crit Care Med 35:1888-95. 2007
    ..To evaluate whether one antibiotic achieves equal outcomes compared with combination antibiotic therapy in patients with Pseudomonas aeruginosa ventilator-associated pneumonia...
  88. ncbi Effects of delayed oxygenation assessment on time to antibiotic delivery and mortality in patients with severe community-acquired pneumonia
    Stijn I Blot
    Intensive Care Department, Ghent University Hospital, Faculty of Medicine and Health Science, Ghent University, Belgium
    Crit Care Med 35:2509-14. 2007
    ....
  89. ncbi Optimal outcome in patients with community-acquired pneumonia: Take the main course before the dessert
    Jordi Rello
    Crit Care Med 33:1149. 2005
  90. ncbi A worldwide perspective of atypical pathogens in community-acquired pneumonia
    Forest W Arnold
    Division of Infectious Diseases, University of Louisville, Louisville, KY 40292, USA
    Am J Respir Crit Care Med 175:1086-93. 2007
    ..In different regions of the world, monotherapy with a beta-lactam antimicrobial is common...
  91. ncbi Secretion of the toxin ExoU is a marker for highly virulent Pseudomonas aeruginosa isolates obtained from patients with hospital-acquired pneumonia
    Grant S Schulert
    Department of Microbiology Immunology, Northwestern University, Chicago, Illinois 60611, USA
    J Infect Dis 188:1695-706. 2003
    ..Together, these findings suggest that secretion of ExoU is a marker for highly virulent strains of P. aeruginosa...
  92. ncbi Optimal therapy for methicillin-resistant Staphylococcus aureus pneumonia: what is the best dosing regimen?
    Jordi Rello
    Chest 130:938-40. 2006
  93. ncbi Clinical impact of pneumonia caused by Acinetobacter baumannii in intubated patients: a matched cohort study
    Jose Garnacho
    Hospital Universitario Virgen del Rocio, Seville, Spain
    Crit Care Med 31:2478-82. 2003
    ..To determine whether ventilator-associated pneumonia caused by Acinetobacter baumannii (VAPAB) is associated with increased mortality rate...
  94. ncbi Improving survival for sepsis: on the cutting edge
    Jordi Rello
    Crit Care Med 31:2807-8. 2003
  95. ncbi Clinical cure and survival in Gram-positive ventilator-associated pneumonia: retrospective analysis of two double-blind studies comparing linezolid with vancomycin
    Marin H Kollef
    Pulmonary and Critical Care Division, Department of Internal Medicine, School of Medicine, Washington University, 660 South Euclid Avenue, St Louis, MO 63110, USA
    Intensive Care Med 30:388-94. 2004
    ..To assess the effect of baseline variables, including treatment, on clinical cure and survival rates in patients with Gram-positive, ventilator-associated pneumonia (VAP)...
  96. ncbi An international prospective study of pneumococcal bacteremia: correlation with in vitro resistance, antibiotics administered, and clinical outcome
    Victor L Yu
    Division of Infectious Disease, University of Pittsburgh, PA, USA
    Clin Infect Dis 37:230-7. 2003
    ..beta-Lactam antibiotics should still be useful for treatment of pneumococcal infections that do not involve cerebrospinal fluid, regardless of in vitro susceptibility, as determined by current NCCLS breakpoints...
  97. ncbi A 7-year study of severe hospital-acquired pneumonia requiring ICU admission
    Jordi Valles
    Critical Care Center, Hospital Sabadell, Institut Universitari Parc Tauli Universitat Autónoma de Barcelona, Parc Tauli s n, 08208, Barcelona, Spain
    Intensive Care Med 29:1981-8. 2003
    ..To examine the characteristics, prognostic factors, and outcome of patients with severe hospital-acquired pneumonia admitted to the ICU...
  98. ncbi Severity of illness assessment for managing community-acquired pneumonia
    Jordi Rello
    Intensive Care Med 33:2043-4. 2007
  99. ncbi Effect of enriched thioglycolate on direct examination of respiratory specimens and guiding initial empirical therapy in intubated patients with pneumonia: a prospective, randomized study
    Jordi Rello
    Intensive Care Department, Hospital de Sabadell, Sabadell, Barcelona, Spain
    Crit Care Med 30:311-4. 2002
    ..To evaluate the use of enriched thioglycolate as a transport medium of protected specimen brush samples, in particular its value in direct examination of respiratory specimens and in guiding initial antibiotic prescription...
  100. ncbi Multicenter, double-blind, placebo-controlled study of the use of filgrastim in patients hospitalized with pneumonia and severe sepsis
    Richard K Root
    University of Washington, Seattle, USA
    Crit Care Med 31:367-73. 2003
    ..To determine the safety and efficacy of filgrastim (r-metHuG-CSF) in combination with intravenous antibiotics to reduce the rate of mortality in patients with pneumonia and sepsis...
  101. ncbi Combination antibiotic therapy lowers mortality among severely ill patients with pneumococcal bacteremia
    Larry M Baddour
    Mayo Clinic, Rochester, NY, USA
    Am J Respir Crit Care Med 170:440-4. 2004
    ..Combination antibiotic therapy improved survival among critically ill patients with bacteremic pneumococcal illness...